Share on StockTwits

Counterpath (NASDAQ:CPAH) was upgraded by Zacks from an “underperform” rating to a “neutral” rating in a research report issued on Monday, American Banking News reports. The firm currently has a $1.10 price objective on the stock. Zacks‘ price objective points to a potential upside of 2.80% from the company’s current price.

Shares of Counterpath (NASDAQ:CPAH) traded down 6.13% on Monday, hitting $1.07. 4,480 shares of the company’s stock traded hands. Counterpath has a 52 week low of $1.41 and a 52 week high of $3.96. The stock has a 50-day moving average of $1.72 and a 200-day moving average of $1.92. The company’s market cap is $45.1 million.

Counterpath (NASDAQ:CPAH) last announced its earnings results on Thursday, December 12th. The company reported ($0.04) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.02) by $0.02. During the same quarter in the previous year, the company posted ($0.01) earnings per share. Analysts expect that Counterpath will post $-0.06 EPS for the current fiscal year.

Separately, analysts at Canaccord Genuity downgraded shares of Counterpath from a “buy” rating to a “hold” rating in a research note on Friday, December 13th.

CounterPath Corporation focuses on the design, development, marketing and sales of personal computer and mobile application software, gateway server software and related professional services, such as pre and post sales, technical support and customization services.

To view Zacks’ full report, visit

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.